Panel Discussion: Developing a More Targeted Approach to Activating Treg Cells to Enhance Efficacy of Treatment in Patients
Time: 9:30 am
day: Day Two
- Addressing the challenge of polyclonal Tregs to outline the risk of effector T cells becoming stimulated and causing damage
- Overcoming the challenge of polyclonal Tregs through development of engineered Treg approaches
- How can clinical outcomes with regulatory T cell therapies be improved?